REQUEST A DEMO
Total
USD $0.00
Search more companies

Diemphar Farmaceutica S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Diemphar Farmaceutica S.A.S. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Diemphar Farmaceutica S.A.S. is based in Ecuador, with the head office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on September 28, 2016. There are currently 4 (2021) people employed by Diemphar Farmaceutica S.A.S.. From the latest financial highlights, Diemphar Farmaceutica S.A.S. reported a net sales revenue drop of 59.1% in 2022. Its’ total assets recorded a growth of 9.99%.

Headquarters
Jose Urbina N24-42
Quito; Pichincha;

Contact Details: Purchase the Diemphar Farmaceutica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Diemphar Farmaceutica S.A.S. report to view the information.
Outstanding Shares:
Purchase the Diemphar Farmaceutica S.A.S. report to view the information.
Registered Capital:
Purchase the Diemphar Farmaceutica S.A.S. report to view the information.
Incorporation Date:
September 28, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Diemphar Farmaceutica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-59.1%
Total operating revenue
-59.29%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
9.99%
Total equity
-91.75%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.8%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?